Maxigen Biotech Inc. (TPE:1783)
46.75
-0.05 (-0.11%)
Jan 22, 2026, 1:35 PM CST
-9.75% (1Y)
| Market Cap | 3.78B |
| Revenue (ttm) | 792.49M |
| Net Income (ttm) | 234.07M |
| Shares Out | 80.69M |
| EPS (ttm) | 2.59 |
| PE Ratio | 18.07 |
| Forward PE | n/a |
| Dividend | 0.83 (1.79%) |
| Ex-Dividend Date | Sep 5, 2025 |
| Volume | 291,068 |
| Average Volume | 128,894 |
| Open | 46.85 |
| Previous Close | 46.80 |
| Day's Range | 46.30 - 47.10 |
| 52-Week Range | 35.55 - 55.00 |
| Beta | 0.23 |
| RSI | 66.61 |
| Earnings Date | Mar 20, 2026 |